What is SMARD1?
A rare genetic disease that affects the nerves controlling movement and breathing
Children with SMARD1 develop progressive muscle weakness. Most importantly, the disease can weaken or paralyse the diaphragm — the main muscle we use to breathe. For many children, this means respiratory failure begins in infancy and long-term ventilatory support becomes necessary.
There is currently no approved treatment that targets the underlying cause. But research — including gene therapy — is advancing.
So how does this connect to tracheostomy?
When the diaphragm grows too weak to sustain breathing on its own, a child may come to depend on a ventilator long term — and a tracheostomy is one of the ways that support can be sustained safely over years rather than weeks.
That is why a rare disease family’s site carries so much about tracheostomy, suctioning, ventilators and home care.
But SMARD1 has never been the only road to the question of whether to go ahead with a tracheostomy — and it is not only children who face it.
Many families arrive here because of an ageing parent or a critically ill relative facing exactly the same questions.
The diagnosis may differ, and so may the age. But once long-term care actually begins, what families face looks remarkably alike — suctioning, home ventilation, navigating the long-term care system, nights you never fully sleep through, and the moments when the caregiver is the one about to break.
So what is recorded here does not belong only to SMARD1.
If you are looking for answers for someone in your own family who needs a tracheostomy, this is written for you too.